Topic: Skin irritation
Test Method Number:
TM2005-04 (EU)
Short Name of TM:
EpiSkin™ - RHE
Year received:
2005
Responsible Organisation:
Protocol(s)/SOP(s):
General Comments:
Method Description
The EpiSkin™ model is a three dimensional reconstructed human epidermis that, once established, comprises of a main basal, supra basal, spinous and granular layers and a functional stratum corneum (the outer barrier layer of skin). The use of the model specifically for skin irritation testing involves the topical application of a test chemical followed by an assessment of cell viability, and specifically cytotoxicity (as measured via the MTT assay). Reductions in cell viability are then expressed as a % of the negative control. The % reduction is then used to predict the irritation potential of a chemical. A substance is considered to be irritating to skin (i.e. categorised as R38) if tissue viability after exposure and post incubation (see protocol, below) is less than or equal to 50%. Cell viability above 50% is considered a marker of a chemical being a non-irritant.Track Approval Status
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
| Step | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Submission | Show status | ||||||||
|
|||||||||
| Validation | |||||||||
| Peer-review | Show status | ||||||||
|
|||||||||
| Recommendation | Show status | ||||||||
|
|||||||||
| Regulatory acceptance/Standards | |||||||||